Patent
Rapid diagnostic device, assay and multifunctional buffer
| العنوان: | Rapid diagnostic device, assay and multifunctional buffer |
|---|---|
| Patent Number: | 8,586,375 |
| تاريخ النشر: | November 19, 2013 |
| Appl. No: | 13/610151 |
| Application Filed: | September 11, 2012 |
| مستخلص: | A rapid diagnostic device, assay and multifunctional buffer reagent are provided for the detection of a target analyte in a fluid test sample. The 2-step assay utilizes a dual component flow-through device comprising a test unit and a dried indicator reagent delivery unit for receiving the fluid sample and multifunctional buffer, respectively. The test unit comprises a reaction zone containing immobilized capture reagent that can bind to the target analyte, an absorbent zone supporting the reaction zone, and optionally, a blood separation zone in lateral fluid communication with the reaction zone. The delivery unit comprises a label zone permeated with a dried indicator reagent which can be placed in transient fluid communication with the reaction zone of the test unit during the assay procedure. The rapid diagnostic assay system reduces the number of assay reagents, method steps and time required for performance compared to other conventional assays. |
| Inventors: | Chan, Hermes K. W. (Halifax, CA) |
| Assignees: | MedMira Inc. (Ontario, CA) |
| Claim: | 1. A method for determining the presence or absence of a target analyte in a fluid test sample, the method comprising the steps of: applying the fluid test sample to a reaction zone of a test unit, whereby the fluid test sample flows downwardly or vertically through the reaction zone, the reaction zone containing an immobilized capture reagent that binds the target analyte in the deposited fluid test sample to form a two-membered complex of a specific binding interaction; allowing the fluid test sample to flow downwardly or vertically through the reaction zone into an absorbent zone in vertical communication with the reaction zone, the absorbent zone comprising an absorbent material positioned underneath the reaction zone for facilitating the downward or vertical flow of the fluid test sample through the reaction zone so as to concentrate the two-membered complex in the reaction zone; affixing a post filter unit to the test unit, such that a label zone of the post-filter unit and the reaction zone of the test unit are proximally disposed, so as to be in transient fluid communication with one another to thereby allow direct downward or vertical fluid flow of a resolubilized dried indicator agent in the label zone to the reaction zone; applying a buffer reagent to the post-filter unit to resolubilize the dried indicator reagent after the fluid test sample is applied to the reaction zone and after the post-filter unit is affixed to the test unit; allowing the resolubilized indicator reagent to flow downwardly or vertically through the reaction zone and into the absorbent zone to bind with the two-membered complex concentrated in the reaction zone, with any unbound reactants being washed from the reaction zone into the absorbent zone; and removing the post-filter unit from the test unit subsequent to the application of the buffer reagent to the label zone and detecting the binding of the resolubilized indicator reagent with the two-membered complex, wherein the indicator reagent is selected from metal complex labels, radioactive labels, fluorescent labels, and chemiluminescent labels. |
| Claim: | 2. The method according to claim 1 , wherein the buffer reagent is a multifunctional buffer comprising: a biological buffer to maintain the pH between 7.0 to 10.0; at least one surfactant to reduce non-specific binding of assay reagents while simultaneously avoiding inhibition of a specific binding interaction; a high molecular weight polymer as a dispersing and suspending reagent having a molecular weight in a range of from about 2×10 2 to about 2×10 6 D; a pH stabilizer to maintain the pH of the multifunctional buffer within a range of about pH 7.0 to 10.0; an ionic salt to reduce non-specific binding of antibodies; at least one preservative to reduce bacterial and microbial growth; and a calcium chelator to prevent a whole blood test sample from clotting; wherein the biological buffer, the surfactant, the high molecular weight polymer, the pH stabilizer, the ionic salt, the preservative and the calcium chelator are all in effective concentrations. |
| Claim: | 3. The method according to claim 1 , wherein the specific binding interaction is an antibody-antigen interaction. |
| Claim: | 4. The method according to claim 3 , wherein the target analyte is an antigen and the capture reagent is a monoclonal antibody or an affinity purified polyclonal antibody for the antigen. |
| Claim: | 5. The method according to claim 1 , wherein the indicator reagent is capable of binding to a target analyte at a site which does not interfere with the specific binding interaction between the target analyte and the capture reagent. |
| Claim: | 6. The method according to claim 1 , wherein the indicator reagent is capable of binding to the capture reagent at a site which interferes with the specific binding interaction between the target analyte and the capture reagent. |
| Claim: | 7. The method according to claim 1 , wherein the reaction zone is comprised of a material which has a pore size permitting separation and filtration of unbound components from the fluid test sample and a thickness which permits an adequate amount of capture reagent to be immobilized thereto. |
| Claim: | 8. The method according to claim 7 , wherein the material has a pore size ranging from about 0.1 to 12.0 microns. |
| Claim: | 9. The method according to claim 8 , wherein the material has a pore size ranging from about 0.2 to 0.8 microns. |
| Claim: | 10. The method according to claim 7 , wherein the thickness of the material ranges from about 0.05 mm to about 30 mm. |
| Claim: | 11. The method according to claim 10 , wherein the thickness of the material ranges from about 0.1 to about 1.0 mm. |
| Claim: | 12. The method according to claim 7 , wherein the material is a nitrocellulose membrane. |
| Claim: | 13. The method according to claim 1 , wherein the reaction zone contains two or more different capture reagents immobilized thereto in discernable and separate areas so that multiple target analytes in a single fluid test sample can be analyzed simultaneously. |
| Claim: | 14. The method according to claim 1 , wherein the reaction zone further comprises an immobilized control reagent in a discernable and separate area from the capture reagent. |
| Claim: | 15. The method according to claim 1 , wherein the absorbent zone is separated from the reaction zone by an intervening spacer layer having one or more openings defined therein to permit fluid communication between the reaction zone and the absorbent zone. |
| Claim: | 16. The method according to claim 15 , wherein the spacer layer is a rigid or semi-rigid fluid-resistant material. |
| Claim: | 17. The method according to claim 1 , wherein the absorbent zone comprises one or more layers of a material which is capable of wicking fluid by capillary action and absorbing a substantial volume of fluid. |
| Claim: | 18. The method according to claim 17 , wherein two or more layers comprise identical or different materials. |
| Claim: | 19. The method according to claim 17 , wherein the material is cellulose acetate. |
| Claim: | 20. The method according to claim 1 , wherein the label zone comprises a filter material having a pore size capable of allowing dried indicator reagent to be effectively resolubilized by buffer reagent and transferred to the reaction zone by laminar fluid flow. |
| Claim: | 21. The method according to claim 20 , wherein the filter material is glass fiber material. |
| Current U.S. Class: | 436/164 |
| Patent References Cited: | 4087567 May 1978 Sullivan 4094647 June 1978 Deutsch et al. 4168146 September 1979 Grubb et al. 4235601 November 1980 Deutsch et al. 4361537 November 1982 Deutsch et al. 4446232 May 1984 Liotta 4517288 May 1985 Giegel et al. 4632901 December 1986 Valkirs et al. 4826759 May 1989 Guire et al. 4912034 March 1990 Kaira et al. 4916056 April 1990 Brown, III et al. 4943522 July 1990 Eisinger et al. 4960691 October 1990 Gordon et al. 5008080 April 1991 Brown, III et al. 5149622 September 1992 Brown et al. 5160701 November 1992 Brown, III et al. 5185264 February 1993 Makela 5459078 October 1995 Kline et al. 5670381 September 1997 Jou et al. 5726013 March 1998 Clark 5763262 June 1998 Wong et al. 5877028 March 1999 Chandler et al. 5879951 March 1999 Sy 6057165 May 2000 Mansour 6087184 July 2000 Magginetti et al. 7531362 May 2009 Chan |
| Other References: | Original of MedMira Laboratories Inc., MedMira Rapid HIV Test Kit Serum or Plasma Testing, 2000, ad for worldwide distribution (two black and white copies). cited by applicant Original of MedMira Laboratories Inc., HIV/HCV Combination Test Instructions, 2000, ad for worldwide distribution (two black and white copies). cited by applicant Original of MedMira Laboratories Inc., Hep B Core Antibody and Hep B Surface Antigen—Instruction on Whole Blood, 2000, ad for worldwide distribution (two black and white copies). cited by applicant Original of MedMira Laboratories Inc., HIV-1/HIV-2 Whole Blood Test Instructions, 2000, instructions for test kit (two black and white copies). cited by applicant Reconstruction of MedMira Laboratories Inc., MedMira Rapid HIV Test Kit Serum or Plasma Testing, 2000, ad for worldwide distribution (one color copy and one black and white copy). cited by applicant Reconstruction of MedMira Laboratories Inc., HIV/HCV Combination Test Instructions, 2000, ad for worldwide distribution (one color copy and one black and white copy). cited by applicant Reconstruction of MedMira Laboratories Inc., Hep B Core Antibody and Hep B Surface Antigen—Instruction on Whole Blood, 2000, ad for worldwide distribution (now retitled as “Hep B Core Antibody and Hep B Surface” (one color copy and one black and white copy). cited by applicant Reconstruction of MedMira Laboratories Inc., HIV-1/HIV-2 Whole Blood Test Instructions, 2000, instructions for test kit (one color copy and one black and white copy). cited by applicant Serum or Plasma Testing; MedMira Laboratories., Mississauga, Ontario, Canada L4W 4T6; 3 Minute Antigen Sensitized Membrane Immunoassay for Direct Detection of HIV 1 & 2 Antibodies. cited by applicant International Preliminary Examination Report in corresponding International Application No. PCT/CA02/01210; Date of Report: Oct. 1, 2003. cited by applicant PCT Written Opinion in corresponding International Application No. PCT/CA02/01210; Mailing Date: Jul. 15, 2003. cited by applicant First Official Action in corresponding Chinese Application No. 02819646.5; Date of Dispatch: Oct. 21, 2005. cited by applicant First Official Action in corresponding European Patent Application No. 02 753 996.4-2404, dated Oct. 7, 2005. cited by applicant |
| Primary Examiner: | Alexander, Lyle |
| Attorney, Agent or Firm: | Sundby, Esq., Suzannah K. Smith, Gambrell & Russell, LLP |
| رقم الانضمام: | edspgr.08586375 |
| قاعدة البيانات: | USPTO Patent Grants |
| الوصف غير متاح. |